JP5379806B2 - 皮膚の保護ケア用テトラペプチド - Google Patents

皮膚の保護ケア用テトラペプチド Download PDF

Info

Publication number
JP5379806B2
JP5379806B2 JP2010531066A JP2010531066A JP5379806B2 JP 5379806 B2 JP5379806 B2 JP 5379806B2 JP 2010531066 A JP2010531066 A JP 2010531066A JP 2010531066 A JP2010531066 A JP 2010531066A JP 5379806 B2 JP5379806 B2 JP 5379806B2
Authority
JP
Japan
Prior art keywords
peptide
skin
peptides
seq
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010531066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502121A (ja
JP2011502121A5 (enExample
Inventor
ツァン，リジュアン
エム． ハリス，スコット
ジェイ． ファラ，ティモシー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helix Biomedix Inc
Original Assignee
Helix Biomedix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix Inc filed Critical Helix Biomedix Inc
Publication of JP2011502121A publication Critical patent/JP2011502121A/ja
Publication of JP2011502121A5 publication Critical patent/JP2011502121A5/ja
Application granted granted Critical
Publication of JP5379806B2 publication Critical patent/JP5379806B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
JP2010531066A 2007-10-29 2008-10-28 皮膚の保護ケア用テトラペプチド Active JP5379806B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81507P 2007-10-29 2007-10-29
US61/000,815 2007-10-29
PCT/US2008/012191 WO2009058244A1 (en) 2007-10-29 2008-10-28 Protective skin care tetrapeptides

Publications (3)

Publication Number Publication Date
JP2011502121A JP2011502121A (ja) 2011-01-20
JP2011502121A5 JP2011502121A5 (enExample) 2011-10-13
JP5379806B2 true JP5379806B2 (ja) 2013-12-25

Family

ID=40305326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010531066A Active JP5379806B2 (ja) 2007-10-29 2008-10-28 皮膚の保護ケア用テトラペプチド

Country Status (9)

Country Link
US (1) US8071555B2 (enExample)
EP (1) EP2205623B1 (enExample)
JP (1) JP5379806B2 (enExample)
KR (1) KR101668803B1 (enExample)
CN (1) CN101855235B (enExample)
CA (1) CA2701420C (enExample)
ES (1) ES2567706T3 (enExample)
PL (1) PL2205623T3 (enExample)
WO (1) WO2009058244A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007093042A1 (en) 2006-02-13 2007-08-23 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in the process of bone remodeling
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
ES2421262T3 (es) * 2007-11-30 2013-08-30 Evonik Goldschmidt Gmbh Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
AU2012274910B2 (en) 2011-06-24 2017-05-11 Nono, Inc. Combination therapy with PSD-95 inhibitor for ischemia
US9241970B2 (en) * 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
CN104254339B (zh) * 2012-04-16 2020-01-21 路博润高级材料公司 用于治疗和/或护理皮肤和/或粘膜的化合物和它们在化妆品组合物或药物组合物中的用途
CA2928851A1 (en) 2012-07-19 2014-01-23 Alethia Biotherapeutics Inc. Anti-siglec-15 antibodies
ES2631804T3 (es) * 2013-06-14 2017-09-05 Helix Biomedix Inc. Tetrapéptidos derivados de quimiocinas humanas C-X-C útiles para el tratamiento de diversas afecciones de la piel
KR20150130616A (ko) * 2014-05-13 2015-11-24 (주)케어젠 피부상태 개선 활성을 갖는 펩타이드 및 이의 용도
US9351911B1 (en) 2015-07-30 2016-05-31 Truth Aesthetics LLC Topical skin care composition providing broad spectrum sunscreen
US9636292B2 (en) 2015-07-30 2017-05-02 Truth Aesthetics LLC Topical skin care composition for night use
CN107629111B (zh) * 2017-10-26 2021-06-04 陕西慧康生物科技有限责任公司 一种乙酰基四肽-2的液相合成方法
KR20210097729A (ko) * 2018-11-30 2021-08-09 인터크 펩타이드 테라퓨틱스 리미티드 피부 병태를 개선하기 위한 폴리펩타이드 및 방법
KR102120992B1 (ko) * 2019-05-03 2020-06-10 (주)위바이오트리 신규한 금속 층상수산화물 복합체 및 이의 제조방법
IT201900008364A1 (it) * 2019-06-07 2020-12-07 Espikem S R L Peptidi bioattivi e composizioni che li comprendono
KR102778423B1 (ko) * 2019-09-26 2025-03-10 (주)아모레퍼시픽 피부 각질세포의 항노화 물질 스크리닝 방법, 스크리닝 키트 및 피부 각질세포의 항노화 물질 함유 조성물
EP4001294A1 (en) * 2020-11-17 2022-05-25 The Boots Company plc Tetrapeptide and compositions comprising tetrapeptides
FR3123193B1 (fr) * 2021-05-28 2025-11-07 Oreal Procédé d’électroporation pour délivrer une composition comprenant au moins un peptide de poids moléculaire allant de 500 Da à 20 kDa
WO2023212118A1 (en) * 2022-04-27 2023-11-02 Sbla Brands Inc. Anti-aging peptide containing cosmetic

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA946837A (en) * 1970-07-28 1974-05-07 Miguel A. Ondetti Enzyme inhibitor
GB2208511A (en) * 1987-08-07 1989-04-05 Bayer Ag Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
WO1989010099A1 (en) 1988-04-21 1989-11-02 Uab Research Foundation Bioelastomeric materials suitable for the protection of wound repair sites from the occurrence of adhesions
DE69033436T2 (de) 1989-04-10 2000-06-21 Helix Biomedix, Inc. Lytische peptide, verwendung als wachstumsfördernde mittel und für infektionen und krebs
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5464820A (en) * 1993-06-22 1995-11-07 The University Hospital Specific inhibitors of tissue kallikrein
US5763576A (en) * 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
FR2741076B1 (fr) * 1995-11-15 1998-01-30 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
EP0858808B1 (en) 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptides for use in wound treatment
GB9702943D0 (en) * 1997-02-13 1997-04-02 Univ Manchester Wound healing
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
US6143742A (en) * 1997-12-11 2000-11-07 Fuisz Technologies Ltd Treatment for necrotizing infections
US6962904B1 (en) * 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
IL138594A0 (en) * 1998-04-01 2001-10-31 Biotech Australia Pty Ltd Use of protease inhibitors for treating skin wounds
CA2312075A1 (en) * 1998-11-05 2001-12-22 Protease Sciences, Incorporated Cosmetic compositions containing human type serine protease inhibitors
US6096327A (en) * 1998-11-05 2000-08-01 Protease Sciences Inc. Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin
FR2788777B1 (fr) * 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
US6492326B1 (en) * 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6284802B1 (en) * 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
CA2276542C (en) 1999-06-28 2013-07-30 Vladislav I. Deigin Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
US6537968B1 (en) * 2000-07-24 2003-03-25 Alphamed Pharmaceuticals Corp Treatment of lupus erythematosus
GB0029777D0 (en) * 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
ES2389285T3 (es) 2001-03-28 2012-10-24 Helix Biomedix, Inc. Péptidos bioactivos cortos y procedimientos para su uso
US20040167072A1 (en) * 2001-05-11 2004-08-26 Aggarwal Bharat B. Inhibitors of receptor activator of NF-kappaB and uses thereof
JP4603240B2 (ja) * 2001-05-11 2010-12-22 リサーチ ディベロップメント ファンデーション ＮＦ−κＢ活性化受容体のインヒビターおよびその使用
US7238656B2 (en) * 2001-08-29 2007-07-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Protective factors against inflammation, burns and noxious stimuli
US7041506B2 (en) * 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
CA2468187A1 (en) * 2001-11-28 2003-06-05 Becton, Dickinson And Company Peptides with growth inhibitory action
US20040009911A1 (en) * 2002-01-31 2004-01-15 Irm, Llc Hepsin substrates and prodrugs
EP1504033A2 (en) * 2002-05-03 2005-02-09 Millenium Biologix Inc. Connective tissue stimulating peptides
US7265097B2 (en) * 2002-08-20 2007-09-04 Chitogenics, Inc. Methods of drug delivery using sulphated chitinous polymers
US7541440B2 (en) * 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
JP4256389B2 (ja) * 2003-11-17 2009-04-22 セダーマ テトラペプチドとトリペプチドの混合物を含む組成物
DE102005000868A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren
DE202004012807U1 (de) 2004-08-13 2004-10-21 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden
DE102004055541A1 (de) 2004-11-17 2006-05-18 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut
DE102004050563A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Kosmetische und der dermatologische Zusammensetzungen mit Wirkstoffen für einen verbesserten Hautkomfort
US7271239B2 (en) * 2004-09-01 2007-09-18 The Research Foundation Of State University Of New York D-isomers of antimicrobial peptide
US20060046271A1 (en) * 2004-09-02 2006-03-02 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
US20070224150A1 (en) * 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
FR2884418B1 (fr) 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
WO2007004869A2 (en) * 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
US20070077305A1 (en) * 2005-10-03 2007-04-05 Le Tien C Biocompatible polymeric matrix and preparation thereof
DE102005063062A1 (de) 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
US7807625B2 (en) * 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition
WO2007098255A2 (en) * 2006-02-21 2007-08-30 President And Fellows Of Harvard College Compositions for and methods of identifying antigens

Also Published As

Publication number Publication date
US20090142280A1 (en) 2009-06-04
US8071555B2 (en) 2011-12-06
KR101668803B1 (ko) 2016-10-24
CN101855235B (zh) 2013-04-24
PL2205623T3 (pl) 2016-09-30
JP2011502121A (ja) 2011-01-20
CA2701420C (en) 2016-02-09
HK1146070A1 (zh) 2011-05-13
WO2009058244A1 (en) 2009-05-07
CN101855235A (zh) 2010-10-06
EP2205623A1 (en) 2010-07-14
ES2567706T3 (es) 2016-04-26
CA2701420A1 (en) 2009-05-07
KR20100083828A (ko) 2010-07-22
EP2205623B1 (en) 2016-03-16

Similar Documents

Publication Publication Date Title
JP5379806B2 (ja) 皮膚の保護ケア用テトラペプチド
ES2547762T3 (es) Péptidos para uso en el tratamiento cosmético o farmacéutico de la piel, membranas mucosas y/o cuero cabelludo
JP7010823B2 (ja) 皮膚、毛髪、爪および／または粘膜の処置および／またはケアにおいて有用な化合物
ES2399581T3 (es) Composiciones cosméticas o farmacéuticas que comprenden inhibidores de metaloproteinasa
US20240352069A1 (en) Synthetic peptide, and cosmetic composition or pharmaceutical composition and application thereof
KR20200024235A (ko) 피부, 모발, 손톱 및/또는 점막의 치료 및/또는 관리에 유용한 화합물
US20220409510A1 (en) Polypeptides And Methods For Improving Skin Conditions
CN105120884A (zh) 用于促进伤口愈合的短生物活性肽
US20150031633A1 (en) Bifunctional peptide
KR101764171B1 (ko) 자외선 광 독성에 대한 펩티드 보호
KR101753874B1 (ko) 데카펩타이드를 유효성분으로 포함하는 화장료 조성물
HK1146070B (en) Protective skin care tetrapeptides
RU2853306C2 (ru) Синтетический пептид и его косметическая или фармацевтическая композиция и применение
CN118206619A (zh) 环九肽及其组合物和用途
KR20220110218A (ko) 화장품 및 의약용 펩타이드 및 조성물
HK1162540B (en) Peptides for use in cosmetic or pharmaceutical treatment of the skin, mucous membranes and/or scalp
KR20190056106A (ko) 창상 치료제로서의 펩타이드의 용도
KR20190056110A (ko) 창상 치료제로서의 펩타이드의 용도

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110823

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130611

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130822

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130917

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130927

R150 Certificate of patent or registration of utility model

Ref document number: 5379806

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250